Kucuk O - Search Results

1

Expression of regeneration and tolerance factor on B cell chronic lymphocytic leukemias: a possible mechanism for escaping immune surveillance.

Aslakson CJ, Lee G, Boomer JS, Gilman-Sachs A, Kucuk O, Beaman KD. Aslakson CJ, et al. Among authors: kucuk o. Am J Hematol. 1999 May;61(1):46-52. doi: 10.1002/(sici)1096-8652(199905)61:1<46::aid-ajh9>3.0.co;2-g. Am J Hematol. 1999. PMID: 10331511 Free article.

2

Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells.

Aller CT, Kucuk O, Springer GF, Gilman-Sachs A. Aller CT, et al. Among authors: kucuk o. Am J Hematol. 1996 May;52(1):29-38. doi: 10.1002/(SICI)1096-8652(199605)52:1<29::AID-AJH5>3.0.CO;2-8. Am J Hematol. 1996. PMID: 8638608 Free article.

3

Antiphospholipid antibodies in sickle cell disease.

Kucuk O, Gilman-Sachs A, Beaman K, Lis LJ, Westerman MP. Kucuk O, et al. Am J Hematol. 1993 Apr;42(4):380-3. doi: 10.1002/ajh.2830420409. Am J Hematol. 1993. PMID: 8493989

4

In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine-enkephalin challenge.

Mosnaim AD, Wolf ME, Maturana P, Mosnaim G, Puente J, Kucuk O, Gilman-Sachs A. Mosnaim AD, et al. Among authors: kucuk o. Immunopharmacology. 1993 Mar-Apr;25(2):107-16. doi: 10.1016/0162-3109(93)90014-h. Immunopharmacology. 1993. PMID: 8500983

5

Intratumor heterogeneity of DNA ploidy and correlations with clinical stage and histologic grade in prostate cancer.

Kucuk O, Demirer T, Gilman-Sachs A, Taw I, Mangold M, Singh S, Westerman MP. Kucuk O, et al. J Surg Oncol. 1993 Nov;54(3):171-4. doi: 10.1002/jso.2930540309. J Surg Oncol. 1993. PMID: 8412173

6

Phase changes in membrane lipids in sickle red cell shed-vesicles and sickle red cells.

Westerman MP, Unger L, Kucuk O, Quinn P, Lis LJ. Westerman MP, et al. Among authors: kucuk o. Am J Hematol. 1998 Jul;58(3):177-82. doi: 10.1002/(sici)1096-8652(199807)58:3<177::aid-ajh3>3.0.co;2-o. Am J Hematol. 1998. PMID: 9662267 Free article.

7

DNA ploidy, proliferative activity, and concanavalin A reactivity in breast cancer.

Paydas S, Sarpel S, Gilman-Sachs A, Tuncer I, Pehlivan S, Tunali N, Zorludemir S, Burgut R, Kucuk O. Paydas S, et al. Among authors: kucuk o. J Surg Oncol. 1994 May;56(1):21-4. doi: 10.1002/jso.2930560106. J Surg Oncol. 1994. PMID: 8176937

8

Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation.

Kies MS, Gordon LI, Rosen ST, Kucuk O, Vriesendorp HM. Kies MS, et al. Among authors: kucuk o. Exp Hematol. 1988 Mar;16(3):190-4. Exp Hematol. 1988. PMID: 3276545

9

Inhibition of cytolytic T lymphocyte activity by oxysterols.

Küçük O, Stoner-Picking J, Yachnin S, Gordon LI, Williams RM, Lis LJ, Westerman MP. Küçük O, et al. Lipids. 1994 Sep;29(9):657-60. doi: 10.1007/BF02536101. Lipids. 1994. PMID: 7815901

10

Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.

Clark JL, Küçük O, Neuberg DS, Benson AB 3rd, Taylor SG 4th, Pandya KJ, Mansour EG, Douglass HO Jr, Haller DG. Clark JL, et al. Among authors: kucuk o. Am J Clin Oncol. 1995 Aug;18(4):318-24. doi: 10.1097/00000421-199508000-00010. Am J Clin Oncol. 1995. PMID: 7625373 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters